CClinicalTrials.gg
CompletedNCT00059410Updated Dec 11, 2009

Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II

An observational study in Alzheimer Disease, sponsored by Alzheimer's Association. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2009-12-11.

Sponsored by Alzheimer's Association · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
210
Sex
All
01

Study summary

The TIPS Study, or Treatment and Illness Perceptions Survey, is a study funded by the national Alzheimer's Association to learn more about differences between African Americans' and Whites' attitudes, beliefs, and experiences related to Alzheimer's disease (AD). The study involves a one-time 30-minute telephone survey in which participants are asked about a range of topics related to AD, including their personal experiences, their beliefs about the disease's symptoms and risk factors, and their attitude toward possible future treatment options. Information from the survey will be used to develop more culturally sensitive health education and healthcare services for persons with AD.

Read the detailed description

The main goal of the Boston University's TIPS II project is to examine differences in Alzheimer's disease (AD) illness perceptions between African Americans and Whites in order to better understand attitudes and beliefs and to develop more culturally sensitive health services for AD. This 30-minute telephone survey will include a total of 140 first-degree relatives and caregivers of people with AD, as well as a comparison group of 70 adults without family history. The researchers will assess 1) beliefs about AD; 2) the perceived threat it poses; 3) sources of information about AD; 4) knowledge of basic facts about AD; 5) appraisal of AD treatments; and 6) intentions regarding current and emerging care options. Based on preliminary data, this study hypothesize that, as compared to Whites, African Americans will report lower levels of perceived threat, fewer sources of information, less awareness of facts, and less interest in care options. Focus group interviews with African American participants will help interpret study findings and inform recommendations for health education interventions.

Findings will inform the development of a set of recommendations for AD health educators that will help them tailor their interventions to African Americans. Such educational programs promote increased use of assessment, treatment, and caregiver assistance services. Results will also be used as pilot data in a proposal for a national survey of caregivers and relatives. This program of research will address a growing need for increased understanding of beliefs, knowledge, and intentions regarding AD. A total of 210 participants are being sought (105 African Americans, and 105 Whites). Participants who complete the survey will be given a $10.00 check, plus informational brochures on AD and the latest newsletter from the Boston University Alzheimer's Disease Center.

02

Conditions studied

  • Alzheimer Disease

Browse trials for

Keywords

  • Alzheimer disease
  • Caregivers
  • African Americans
  • Perceptions
  • Cultural Competency
03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's enrollment of 210 is close to the median of 200 across 751 observational studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

Alzheimer's Association is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Three groups of participants are sought to take part in the survey:

  • 70 primary caregivers(current or former) of persons with AD, or related memory disorders
  • 70 adult children and siblings of people with AD or related memory disorders
  • 70 adults age 40 and older without immediate family history of AD or related memory disorders

Exclusion criteria

Exclusion Criteria:

  • Not fluent in English
  • Cognitive impairment that would preclude responding to a 30-minute telephone survey
05

Study design

Time perspective
Prospective
Enrollment
210 participants
06

Study locations

1 site
  • Boston University School of Medicine, Alzheimer's Disease Center
    Boston, Massachusetts 02118, United States
07

References and documents

Publications

  • Roberts JS, Connell CM. Illness representations among first-degree relatives of people with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000 Jul-Sep;14(3):129-136,Discussion 127-8. doi: 10.1097/00002093-200007000-00003. PubMed 10994653 ↗
  • Roberts JS. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Gerontologist. 2000 Feb;40(1):43-52. doi: 10.1093/geront/40.1.43. PubMed 10750312 ↗
  • Roberts JS, Connell CM, Cisewski D, Hipps YG, Demissie S, Green RC. Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer Dis Assoc Disord. 2003 Jan-Mar;17(1):19-26. doi: 10.1097/00002093-200301000-00003. PubMed 12621316 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00059410
Lead sponsor
Alzheimer's Association
First posted
Apr 28, 2003
Start date
Jan 2003
Primary completion
Sep 2005
Completion
Sep 2005
Last update
Dec 11, 2009

Study contacts

Scott Roberts, PhD
study director · Boston University Alzheimer's Disease Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion